What is the ticker symbol for PHAXIAM Therapeutics S.A.?

PHAXIAM Therapeutics S.A. trades under the ticker PHXM on NASDAQ.

What sector does PHAXIAM Therapeutics S.A. operate in?

PHAXIAM Therapeutics S.A. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PHXM in a portfolio?

PortView shows PHXM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

PHAXIAM Therapeutics S.A. (PHXM) Stock Analysis

NASDAQHealthcareBiotechnology

$3.10-5.20%

1-year price historyRange $2.50 – $12.20

52-week range$3.10

$2.50$13.00

What PHAXIAM Therapeutics S.A. does

PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, which is currently undergoing Phase 3 clinical trials for advanced pancreatic cancer (second-line treatment) and Phase 2 studies for triple-negative breast cancer and relapsed acute lymphoblastic leukemia. Additionally, PHAXIAM is advancing a range of phage-based therapies designed to combat severe, drug-resistant bacteria. These pathogens are responsible for over two-thirds of nosocomial (hospital-acquired) infections that resist conventional treatments, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Established in 2004 and headquartered in Lyon, France, the company was previously known as ERYTECH Pharma S.A. before adopting its current name, PHAXIAM Therapeutics S.A., in June 2023.

Key metrics

Market cap

$19.86M

P/E (TTM)

-2.67

EPS (TTM)

$-1.16

Beta

1.80

Dividend yield

0.00%

Revenue / share

$0.28

50-day avg

$3.88

200-day avg

$5.17

52-week high

$13.00

52-week low

$2.50

CEO

Eric Soyer

ETFs linked to PHXM

Broad-market and Healthcare sector ETFs an investor holding PHAXIAM Therapeutics S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PHXM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PHXM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for PHAXIAM Therapeutics S.A.?: PHAXIAM Therapeutics S.A. trades under the ticker PHXM on NASDAQ.
Which exchange is PHXM listed on?: PHXM is listed on NASDAQ.
What sector does PHAXIAM Therapeutics S.A. operate in?: PHAXIAM Therapeutics S.A. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PHXM in a portfolio?: PortView shows PHXM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.